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The selective oxidation of substituted aromatic hydrocarbons and 
the observation of uncoupling via redox cycling during 
naphthalene oxidation by the CYP101B1 system 
Emma A. Hall, Md Raihan Sarkar and Stephen G. Bell* 
The cytochrome P450 monooxygenase enzyme CYP101B1, from Novosphingobium aromaticivorans DSM12444, efficiently 
and selectively oxidised a range of naphthalene and biphenyl derivatives. Methyl substituted naphthalenes were better 
substrates than ethylnaphthalenes and naphthalene itself. The highest product formation activity for a singly substituted 
alkylnaphthalene was obtained with 2-methylnaphthalene. The oxidation of alkylnaphthalenes was regioselective for the 
benzylic methyl or methine CH bonds. The products from 1- and 2-ethylnaphthalene oxidation were highly enantioselective 
with a single stereoisomer being generated in significant excess. The disubstituted substrate, 2,7-dimethylnaphthalene, had 
a higher product formation activity than either 1- and 2-methylnaphthalene. Methyl substituted biphenyls were also better 
substrates than biphenyl and had similar biocatalytic parameters to 1-methylnaphthalene. CYP101B1 catalysed oxidation of 
2- and 3-methylbiphenyl was selective for attack at the methyl CH bonds. The exception was the turnover of 4-
methylbiphenyl which generated 4`-(4-methylphenyl)phenol as the major product (70%) with 4-biphenylmethanol making 
up the remainder. The drug molecule diclofenac was also regioselectively oxidised to 4-hydroxydiclofenac by CYP101B1. 
The activity of the CYP101B1 system with naphthalene was more complex and the rate of NADH oxidation increased over 
time but very little product, 1-naphthol, was generated. Addition of 1-naphthol and 2-naphthol and low concentrations of 
1,4-naphthoquinone induced rapid NADH oxidation activity in the in vitro turnovers but the rate of oxidation was similar in 
the absence of the cytochrome P450 enzyme. Hydrogen peroxide was generated in these reactions in absence of the P450 
enzymes demonstrating that the ferredoxin and ferredoxin reductase in combination with naphthol oxidation products and 
oxygen can undergo redox cycling giving rise to a form of uncoupling of the reducing equivalents.
Introduction 
There is great interest in applying cytochrome P450 (CYP) 
enzymes as biocatalysts for the regio- and stereo-selective 
insertion of an oxygen atom into chemically inert carbon-
hydrogen bonds.1-7 This monooxygenase activity requires two 
electrons that are usually derived from NAD(P)H and these are 
delivered one at a time, as required, to the CYP enzymes by 
electron transfer proteins.8 Electron transfer is often the rate 
determining step in CYP catalysis and the activities of many CYP 
enzymes are compromised when alternative electron transfer 
systems are used.9-11 In addition uncoupling reactions which can 
arise from poor enzyme/substrate compatibility and leakage 
due to oxygen reduction competing with slow inter-protein 
electron transfer can reduce the effectiveness of the enzyme. 
Both result in oxygen reduction without product formation.12-14 
The identification and application of highly active 
monooxygenase systems greatly facilitates biocatalytic CH 
bond oxidation of hydrocarbons and aromatics.15-17 Therefore 
the isolation and characterisation of new complete systems 
which are capable of performing challenging reactions, such as 
the selective oxidation of aromatic molecules, is of paramount 
importance in the field of fine chemical synthesis.  
Many bacterial and fungal monooxygenase enzymes have 
been investigated as potential biocatalysts for the oxidation 
aromatic molecules.18-20 The fungal peroxygenases from 
Agrocybe aegerita and Coprinellus radians were able to oxidise 
a broad range of polyaromatic hydrocarbons.21 Certain 
members of the self-sufficient CYP102 family of P450 
monooxygenases, which are highly active for fatty acid 
substrates, have activity with aromatic substrates.2, 16 
CYP102A1, from Bacillus megaterium, has been modified via 
protein engineering to facilitate the oxidation of aromatic 
substrates such as naphthalene, phenanthrene and pyrene.2, 22 
Class I CYP enzymes, such as CYP101A1 (P450cam), from a 
Pseudomonas sp., whose electron transfer systems consist of a 
flavin-dependent ferredoxin reductase and a ferredoxin, are 
also capable of high monooxygenase activities and selective 
oxidations.11, 23, 24 The wild-type forms of various class I CYP 
enzymes and mutants of CYP101A1, have been reported to be 
biocatalysts for the oxidation of aromatic molecules including 
polyaromatic hydrocarbons and biphenyl.25-29  
Naphthalene, methylnaphthalenes and substituted 
biphenyls are toxic molecules which are ubiquitous in the 
environment.30 Substituted naphthalene and biphenyl 
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derivatives are also found in a range of molecules with 
pharmacological activity including drug molecules such as 
diflunisal, naftifine, terbinafine and tolnaftate. The enzyme 
catalysed oxidation of these aromatic substrates has potential 
applications in environmental bioremediation and fine chemical 
synthesis. The Phe87Val mutant form of CYP102A1 has been 
used to oxidise naphthalene derivatives, including the methyl 
and dimethyl substituted forms.31 CYP110E1, from Nostoc sp. 
strain PCC7120, oxidised substituted naphthalenes and 
biphenyls.32 The reducing equivalents were provided to 
CYP110E1 by fusing the enzyme to the RhFred reductase 
domain of CYP116B2 from Rhodococcus sp. NCIMB 9784.33 The 
turnovers of substituted naphthalenes by both of these 
monooxygenase enzymes were generally not selective with at 
least two products being generated in low yields for each 
substrate.31, 32 The fungal peroxygenases from Agrocybe 
aegerita and Coprinellus radians efficiently oxidised 1- and 2-
methylnaphthalene unselectively to numerous products 
including those arising from multiple oxidations.34 
Novosphingobium bacteria are able to degrade a variety of 
aromatic hydrocarbons and therefore the oxygenase enzymes 
from these species have the potential to be biocatalysts for the 
oxidation of these hydrophobic substrates.35, 36 The bacterium 
Novosphingobium aromaticivorans DSM12444 contains many 
monooxygenase and dioxygenase enzyme coding genes.35 The 
cytochrome P450 monooxygenase CYP108D1 from N. 
aromaticivorans has been shown to bind biphenyl, 
naphthalene, phenanthrene and phenylcyclohexane.20 
CYP101B1 from the same bacterium, which is related to 
CYP101A1, CYP101C1, CYP101D1 and CYP101D2 (the last three 
also being from N. aromaticivorans), oxidised indole generating 
indigo.11, 37-39 We have reported that the CYP101B1 enzyme is 
an active biocatalyst for the oxidation of norisoprenoids and can 
turnover other structurally diverse substrates including 
phenylcyclohexane and various esters.37, 40-44 Importantly a 
class I electron transfer system, consisting of a flavin-dependent 
ferredoxin reductase, ArR, and a [2Fe-2S] ferredoxin, Arx, has 
been identified from this bacterium. This electron transfer 
system supports the activity of CYP101B1, as well as those of 
CYP101D1, CYP101D2, CYP101C1 and CYP111A2 but not that of 
CYP108D1.11, 20, 37, 40, 41 The product formation activity with the 
best substrates is in excess of 1000 nmol.nmol P4501.min1. A 
whole-cell system containing CYP101B1, ArR and Arx, which is 
capable of product formation on the gram-per-liter scale in 
shake flasks, has been constructed.37 Therefore CYP101B1 is a 
promising monooxygenase system for biocatalytic applications 
involving CH bond oxidation reactions. 
Aromatic molecules including phenylcyclohexane and p-
cymene have been oxidised by CYP101B1 with the activity of 
phenylcyclohexane oxidation being five times higher than the 
oxidation of p-cymene.41 Phenylcyclohexane was selectively 
oxidised to trans-4-phenylcyclohexanol while p-cymene was 
hydroxylated at the benzylic carbons to yield a mixture of 
isopropylbenzyl alcohol and p-,-trimethylbenzylalcohol. 
Despite inducing a lower shift to the high spin form (20%) 
compared to norisoprenoids, phenylcyclohexane binds to 
CYP101B1 with comparable affinity to -damascone suggesting 
that larger two ring aromatic systems may be good substrates 
for this enzyme.41 Many drug molecules contain multiple 
aromatic rings and the identification and synthesis of drug 
metabolites using soluble and highly active P450 enzymes could 
simplify the drug development process. Here we report that the 
substrate range of CYP101B1 includes aromatic substrates and 
demonstrate it is a capable of acting as a biocatalyst for the 
oxidation of substituted naphthalenes, biphenyls and the drug 
molecule diclofenac. During these investigations we 
determined that the oxidation products of naphthalene could 
interfere with the transfer of the electrons from the ferredoxin 
to the P450 enzyme which provided an alternate mechanism for 
uncoupling via unproductive redox cycling in these systems. 
Experimental 
General 
General reagents and organics were from Sigma-Aldrich, TCI, 
Acros or VWR. Buffer components (Tris-HCl) NADH, and 
isopropyl--D-thiogalactopyranoside (IPTG) were from 
Anachem (Astral Scientific, Australia) or Biovectra, (Scimar, 
Australia). General DNA manipulations and microbiological 
experiments and the expression, purification and quantitation 
of CYP101B1 and the electron transfer proteins ArR and Arx 
from N. aromaticivorans were performed as described 
previously.37, 40  
Substrate binding and kinetic analysis 
UV/Vis spectroscopy was performed on Varian Cary 5000 or 
Agilent Cary 60 spectrophotometers. For substrate binding the 
P450 enzymes were diluted to 3.5 - 10 µM using 50 mM Tris, 
pH 7.4. After addition of the substrate (as 1 µL aliquots from a 
50 mM stock in DMSO or ethanol) the high spin heme content 
was estimated, to approximately ±5%, by comparison with a set 
of spectra generated from the sum of the appropriate 
percentages of the spectra of the substrate-free form (>95% low 
spin, Soret maximum at 418 nm) and camphor-bound form 
(>95% high spin, Soret maximum at 392 nm) of wild-type 
CYP101A1. 
To determine the dissociation constant of CYP101B1 with 1-
methylnaphthalene the enzyme was diluted to 2.1 µM in a total 
volume of 2.5 mL in 50 mM Tris, pH 7.4 and used to baseline the 
spectrophotometer. Aliquots of 1-methylnaphthalene (0.5 - 2 
µL) were added using a Hamilton syringe from a 1, 10 or 50 mM 
stock solution in DMSO. The solution was mixed and the peak-
to-trough difference in absorbance recorded between 700 nm 
and 250 nm. Further aliquots of substrate were added until the 
peak-to-trough difference of the Soret band did not shift 
further. The apparent dissociation constant, Kd, was obtained by 
fitting the peak-to-trough difference against substrate 
concentration to a hyperbolic function (Eqn. 1):  
where ΔA is the peak-to-trough absorbance difference, ΔAmax 
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NADH turnover assays were performed with mixtures (1.2 
mL) containing 50 mM Tris, pH 7.4, 0.5 μM CYP101B1, 5 μM Arx, 
0.5 μM ArR and 100 μg mL–1 bovine liver catalase. The buffer 
component was oxygenated by bubbling oxygen through the 
solution before addition of the other components and 
equilibration at 30 °C for 2 min. NADH was added to ~320 μM, 
final A340 = 2.00, and the absorbance at 340 nm was monitored. 
Substrates were added from a 100 mM stock solutions in 
ethanol or DMSO to a final concentration of 0.25  0.5 mM. The 
rate of NADH turnover was calculated using ε340 = 6.22 mM–1 
cm–1 (Table 1). Where required turnovers using 4 mM NADH 
were undertaken in order to generate sufficient product for GC 
coelution experiments (the rate of NADH oxidation was not 
monitored). 
The concentration of hydrogen peroxide formed during 
NADH oxidation in the absence of CYP101B1 was determined by 
the horseradish peroxidase/phenol/4-aminoantipyrine assay.45 
The total assay volume was 800 µL and contained 200 µL of 50 
mM Tris, pH 7.4, 400 µL of a reaction mixture, 100 µL of 100 mM 
phenol and 100 µL of 10 mM 4-aminoantipyine (both in 50 mM 
Tris pH 7.4). The absorbance at 510 nm was set to zero, 1 L of 
a 20 mg mL–1 solution of horseradish peroxidase in water was 
then added, and the absorbance recorded (510 = 6580 M–1 cm–
1).  
Product formation 
Where authentic product standards were available they were 
utilised for identification purposes via HPLC/GC-MS coelution 
experiments. The product concentration in the incubation 
mixtures was calculated by calibrating the UV detector response 
of the HPLC detector or GC-MS to the total ion count (TIC) to the 
products. The coupling efficiency was the percentage of NADH 
consumed that led to product formation. HPLC analyses were 
performed using an Agilent 1260 Infinity pump equipped with 
an Agilent Eclipse Plus C18 column (250 mm x 4.6 mm, 5 µm), 
an autoinjector and UV detector (monitored at 280 nm for 
naphthalene turnovers and 254 nm for biphenyl and diclofenac 
assays). A gradient, 20  95%, of acetonitrile (with 
trifluoroacetic acid, 0.1%) in water (TFA, 0.1%) was used. The 
HPLC retention times were as follows; 1-methylnaphthalene, 
22.4 min; 1-naphthylmethanol, 15.1 min; 2-methylnaphthalene, 
22.4 min; 2-naphthylmethanol, 15.3 min; 2,7-
dimethylnaphthalene, 24.4 min; 2-(7-
methylnaphthyl)methanol, 17.0 min; 7-methyl-2-naphthoic 
acid, 17.6 min; 1-ethylnaphthalene, 23.7 min; 1-naphthyl-1-
ethanol, 16.6 min; 2-ethylnaphthalene, 24.1 min; 2-naphthyl-1-
ethanol, 16.5 min; 2-methylbiphenyl, 23.7 min; 2-
biphenylmethanol, 17.4 min; 3-methylbiphenyl, 23.7 min; 3-
biphenylmethanol, 17.2 min; 4-methylbiphenyl, 23.7 min;  4-
biphenylmethanol, 17.1 min; 4-(4-methylphenyl)phenol, 19.2 
min; 4-(4-hydroxyphenyl)benzyl alcohol, 13.0 min; diclofenac, 
20.0 min and 4′-hydroxydiclofenac, 16.7 min. The internal 
standard retention times were 9-fluorenone, 16.6 min and 4-
methoxycinnamic acid, 12.6 min. 
 Gas chromatography–mass spectrometry (GC-MS) analyses 
were carried out on a Shimadzu GC-17A instrument coupled to 
a QP5050A MS detector using a Zebron DB-5 MS fused silica 
column (Phenomenex; 30 m x 0.25 mm, 0.25 µm) and helium as 
the carrier gas. The retention times were as follows 1-naphthol 
11.0 min; 1,4-naphthoquinone, 9.8 min; 2,6-
dihydroxynaphthalene, 14.7 min; 2-naphthol, 11.2 min; 
biphenyl, 9.6 min; 2-phenylphenol, 11.1 min; 4-phenylphenol, 
13.2 min; 3-methylbiphenyl, 10.8 min; 3-phenylbenzaldehyde, 
13.0 min; 3-biphenylmethanol, 13.8 min; 4-methylbiphenyl, 
10.9 min; 4-biphenylmethanol, 13.9 min and 4-(4-
methylphenyl)phenol, 14.3 min. Chiral and additional GC 
analysis was performed on a Shimadzu Tracera GC coupled to 
Barrier discharge Ionization Detector (BID) detector using a RT®-
BDEXse chiral silica column (Restek; 30 m x 0.32 mm x 0.25 um) 
or a SH-Rxi-5ms fused silica column (Shimadzu, 30 m x 0.25 mm, 
0.25 µm) and helium as the carrier gas. Retention times are 
given in the supporting information (Fig. S2). 
Product isolation and characterisation  
To isolate and identify products where standards were not 
available a whole-cell oxidation system utilising the plasmids 
pETDuetArx/ArR and pRSFDuetArx/CYP101B1 was used to 
oxidise substrates. Two aliquots of 0.5 mM were added, one at 
the beginning of the turnover and the second after 6 hrs, as 
described previously.27, 37 The supernatant (200 mL) was 
extracted in ethyl acetate (3 x 100 mL), washed with brine (100 
mL) and dried with magnesium sulfate. The organic extracts 
were pooled and the solvent was removed by vacuum 
distillation and then under a stream of nitrogen. The products 
were purified using silica gel chromatography using a 
hexane/ethyl acetate stepwise gradient ranging from 80:20 to 
50:50 hexane to ethyl acetate using 2.5% increases every 100 
mL. The composition of the fractions was assessed by TLC and 
GC-MS and those containing single products (95%) were 
combined for characterisation. The solvent was removed under 
reduced pressure.  
The purified products (ranging from 3 - 15 mg) were 
dissolved in CDCl3 or d6-acetone and the organics characterised 
by NMR spectroscopy. NMR spectra were acquired on an 
Agilent DD2 spectrometer operating at 500 MHz for 1H and 126 
MHz for 13C or a Varian Inova-600 spectrometer operating at 
600 MHz for 1H and 151 MHz for 13C. A combination of 1H, 13C, 
COSY and HSQC experiments were used to determine the 
structures of the products. Assignments of minor products were 
made via GC coelution or comparison of MS spectra of 
standards published by others (Fig. S4). 
NMR Data 
Data for 2-(7-methylnaphthyl)methanol: 1H NMR (500 MHz, d6-
acetone)  7.79 (s, 1H), 7.77 (m, 1H), 7.75 (m, 1H), 7.63 (s, 1H), 
7.46 (m, 1H), 7.33 (m, 1H), 4.77 (s, 2H), 2.48 (s, 3H). 
Data for 7-methyl-2-naphthoic acid: 1H NMR (500 MHz, d6-
acetone)  8.64 (s, 1H), 8.07 (m, 1H), 8.02 (m, 1H), 7.93 (m, 1H), 
7.80 (s, 1H), 7.50 (m, 1H), 2.57 (s, 3H). 13C NMR (126 MHz, d6-
acetone)  168.38 (C11), 139.78 (C9), 137.26 (C10), 132.31 (C7), 
132.06 (C1), 130.52 (C5), 130.36 (C6), 128.85 (C4), 128.51 (C2), 
128.09 (C8), 126.83 (C3), 22.35 (C12). 
Data for 3-biphenylmethanol: 1H NMR (500 MHz, CDCl3)  7.64 
 7.57 (m, 3H), 7.53 (m, 1H), 7.64 – 7.57 (m, 3H), 7.39  7.31 (m, 
2H), 4.77 (s, 2H). 
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Data for 4′-(4-methylphenyl)phenol: 1H NMR (500 MHz, CDCl3) 
 7.45 (m, 2H), 7.43 (m, 2H), 7.22 (m, 2H), 6.88 (m, 2H), 2.38 (s, 
3H). 
Data for 4′-(4-hydroxyphenyl)benzyl alcohol: 1H NMR (500 
MHz, d6-acetone)  7.54 (m, 2H), 7.50 (m, 2H), 7.40 (m, 2H), 6.92 
(m, 2H), 4.65 (s, 2H). 
Data for 4`-hydroxydiclofenac:46, 47 1H NMR (600 MHz, d6-
DMSO)  7.10 (m, 1H, H4), 7.00  6.96 (m, 1H, H6), 6.93 (s, 2H, 
2 x H3`), 6.71 (m, 1H, H5), 6.10 (m, 1H, H7), 3.60 (s, 2H, H2). 13C 
NMR (151 MHz, d6-DMSO) 176.84 (C1), 155.67 (C4`), 144.68 
(C8), 133.08 (C1`), 131.04 (C4), 128.63 (C2`), 127.66 (C6), 123.59 
(C3), 119.31 (C5), 116.26 (C3`), 113.97 (C7), 35.98 (C2). 
Results and discussion 
The oxidation of naphthalene and biphenyl by CYP101B1 
To investigate the ability of CYP101B1 to oxidise aromatic 
compounds we analysed naphthalene and biphenyl, each of 
which contain two aromatic benzene rings (Fig. 1). Substrate 
binding and enzyme turnover activity were measured using in 
vitro assays. Neither biphenyl nor naphthalene induced a large 
type I spin-state shift on binding to CYP101B1, both 20% high 
spin (HS) (Table 1, Fig. S1). The low solubility and relatively weak 
binding precluded the accurate determination of the 
dissociation constant for both of these substrates.  
Fig. 1 Substrates tested with CYP101B1 
Despite this, the addition of naphthalene and biphenyl 
enhanced the rate of NADH oxidation of the ArR/Arx/CYP101B1 
system above the leak rate (the rate of NADH oxidation in the 
absence of substrate, Table 1). The NADH oxidation activity of 
the CYP101B1 system with naphthalene was unusual in that it 
accelerated from an initial rate of 90 nmol-nmol P4501-min1 
(henceforth abbreviated to min1) over the course of the 
reaction (Fig. 2a). HPLC and GC-MS analysis of the turnovers 
revealed minimal levels of the expected naphthol products or 
any others (Fig. S2). Therefore it appears that the coupling 
efficiency, which is the productive use of the NADH reducing 
equivalents, of naphthalene oxidation by CYP101B1 must be 
very low. In vitro turnovers conducted with a large excess of 
NADH (4 mM, twelve times the amount in the normal turnover 
assays) allowed the identification of low levels of 1-napthol as a 
product from the CYP101B1 catalysed turnover of naphthalene 
(Scheme 1, Fig. S2a). Under these conditions biphenyl was 
oxidised to 4-phenylphenol but the level of product formation 
was also very low (Fig. S2b).  
Table 1 Substrate binding and kinetic data for CYP101B1 with naphthalene, biphenyl, 
naphthols and phenylphenols. The turnover activities were measured using a 
ArR:Arx:CYP101B1 concentration ratio of 1:10:1 (0.5 μM CYP enzyme, 50 mM Tris, pH 
7.4). Rates are reported as mean  S.D. (n  3) and given in nmol.nmol-CYP–1.min–1.[a] 
[a] Note for ease of comparison the NADH oxidation rates provided in the main 
text in the absence of the CYP101B1 enzyme are given in the same units as if the 
P450 enzyme was present. [b] An estimate of the initial rate of NADH oxidation as 
the rate increased over time (Fig. 2). 
To investigate if the increasing NADH oxidation rate 
observed in the CYP101B1 turnovers of naphthalene arose from 
further oxidation of naphthol products, and to determine if we 
could identify any product arising from such activity, we tested 
1- and 2-naphthol as substrates. 1-Naphthol induced a larger 
spin state shift (65%, HS) on binding to CYP101B1 than 
naphthalene, and that induced by 2-naphthol (40%, HS) lay 
inbetween (Table 1, Fig S1). The NADH oxidation activity of both 
naphthols was significantly greater than naphthalene. That of 1-
naphthol (2090 min1) being almost 4-fold more active than 2-
naphthol (560 min1, Table S1, Fig. S3). Analysis of the standard 
in vitro assays was inconclusive for product formation with 
naphthol substrates due to the low level of metabolites 
generated. Using excess NADH (4 mM) we were able to detect 
low levels of product from the oxidation of 1- and 2-naphthol 
(Fig. S2c and S2d). 2-Naphthol oxidation resulted in a single 
metabolite which was assigned as 2,6-dihydroxynaphthalene by 
GC coelution experiments with an authentic product standard 
and analysis of the mass spectrum (Fig. S4).48 There was no 
evidence of either 2-naphthol or the further oxidation product, 
2,6-dihydroxynaphthalene, in the CYP101B1 turnovers of 
naphthalene (Scheme 1, Fig S2). The product from 1-naphthol 
oxidation was assigned as 1,4-naphthoquinone based on GC 
coelution and the mass spectrum (Fig. S2c).48, 49 A small peak, 
which coeluted with the 1,4-naphthoquionone, was observed in 
the turnovers of naphthalene and was also present in the 1-







    
naphthalene   15% 90  25[b] 
1-naphthol  65% 2090  90 
2-naphthol  40% 560  60 
biphenyl  15% 200  10 
2-phenylphenol  35% 90  1 
3-phenylphenol  40% 80  8 
4-phenylphenol  40% 110 10 
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Fig. 2 NADH oxidation assays of CYP101B1 with (a) naphthalene and (b) 1-naphthol 
(red), 1-naphthol no P450 control (blue) and 1-naphthol, no Arx and P450 control 
(black). 
Importantly the quantities of naphthalene and naphthol 
remaining in these turnovers when excess NADH was used were 
also high. Further oxidation products, such as those arising from 
oxidative aryl coupling also do not appear significant.31, 50, 51 This 
and the low levels of product formation in the above assays 
indicated that further oxidation of 1-napthol or 2-napthol is 
unlikely to be the major reason for the acceleration in the NADH 
oxidation activity observed in the naphthalene turnovers 
(Scheme 1, Fig. S2a). Control experiments were performed in 
which the CYP101B1 enzyme was omitted from the turnover. 
The rate of NADH oxidation in the presence of just the ArR and 
Arx electron transfer proteins with 1-naphthol (1 mM) was 1560 
min1 (Fig. 2). The rate of NADH oxidation in the presence of 2-
naphthol in these control reactions, was lower but was similar 
to that observed in the fully reconstituted in vitro turnover 
(Table 1). When both Arx and CYP101B1 were absent the rate 
of NADH oxidation dropped dramatically and was similar to the 
leak rate in the absence of substrate (Fig. 2). We also tested 1,4-
naphthoquinone with the Arx and ArR electron transfer 
partners. The addition of 1,4-naphthoquinone resulted in the 
rapid oxidation of NADH even at concentrations as low as 8 M 
(2600 min1) with lower concentrations resulting in significant 
activity (4 M, 1300 min1, 50 nM; 320 min1) Analysis of these 
naphthol and naphthoquinone turnovers in the absence and 
presence of CYP101B1 showed that the majority, >95%, of the 
reducing equivalents ended up as hydrogen peroxide.  
Scheme 1 The products identified from the CYP101B1 turnovers of the 
naphthalene substrates. 
Similar experiments were performed with the three possible 
phenylphenol products of biphenyl oxidation. The addition 
polyphenols to CYP101B1 shifted the spin state to a greater 
degree than biphenyl (35-40%, Table 1) but the NADH oxidation 
activities were all lower than that of biphenyl and much lower 
than those of the naphthols (≤110 min1, Table 1). The NADH 
oxidation rate in the absence of CYP101B1 was also similar to 
those of the phenylphenols in the normal turnover assays but 
the levels of hydrogen peroxide generated were low for 2- and 
4-phenylphenol (< 10 µM). The levels were slightly higher for 3-
phenylphenol (20 µM).  
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The data suggests that the unusual behavior of naphthalene 
oxidation by the ArR/Arx/CYP101B1 system is predominantly 
due to an increase in the NADH oxidation activity of the system 
in the presence of small quantities of 1,4-naphthoquinone. This 
arises from hydroxylation of naphthalene to 1-napthol followed 
by further oxidation to the quinone. Rather than 1,4-
naphthoquinone acting as a substrate or promoting established 
P450 uncoupling pathways it accepts electrons from Arx and in 
the aerobic environment of the turnover was able to reduce 
oxygen. Oxygen is likely to be reduced to superoxide which 
dismutates to hydrogen peroxide and singlet oxygen. This 
would be similar to reactivity reported for NADPH cytochrome 
P450 reductase with quinones and nitroaromatics and that 
observed with the leaking of reducing equivalent in the 
adrenodoxin mitochondrial system.52-54 The reduction of 
oxygen by the mitochondrial electron transfer system in the 
absence of substrate and the P450 enzyme has been described 
before.54, 55 The acceleration of this uncoupling pathway by 
exogenous substrates has not been described in great detail 
with bacterial or mitochondrial electron transfer systems 
containing ferredoxins.5, 12, 56-58 This redox cycling competes 
with electron transfer to CYP101B1 and therefore reduces the 
levels of metabolite formation. This resulted in low levels of 
productive P450 catalysis despite high levels of NADH oxidation 
activity and should be considered an additional form of 
uncoupling in P450 systems. Further investigations are required 
to determine the exact mechanism of the transfer of the 
electrons from the ferredoxin to the naphthoquinone and the 
subsequent generation of hydrogen peroxide. It would also be 
important to ascertain if this behaviour is generic across the 
class I electron transfer systems and to understand the 
structural features of the molecules which can interfere with 
the electron transfer process in this way.57, 58 The increase in the 
rate of futile redox cycling during the turnovers was greatest for 
the oxidation products arising from naphthalene oxidation to 1-
naphthol and 1,4-naphthoquinone with minimal activity of this 
type being observed with phenylphenols, biphenylmethanols or 
naphthylmethanols (vide infra). The 1,4-naphthoquinone and 
2,6-dihydroxynaphthalene metabolites which arose from the 
turnovers of the naphthols are the same as those observed in 
the metabolism of these substrates by mammalian P450 
enzymes.59, 60This phenomenon is likely to have important 
implications for understanding the toxicity of polyaromatic 
hydrocarbons and their oxygenated metabolites such as 
quinones.61, 62 
 
Oxidation of substituted two ring aromatic molecules by 
CYP101B1 
The low productive monooxygenase activity of CYP101B1 with 
naphthalene and biphenyl, led us to investigate similar 
substrates which contain more reactive benzylic aliphatic CH 
bonds (Fig. 1). 1-Methylnaphthalene bound to CYP101B1, with 
a spin state shift of 55% HS (Fig. S1) which is greater than 
naphthalene and almost as high as 1-naphthol. We were able to 
measure the dissociation constant of 1-methylnaphthalene 
binding to CYP101B1, Kd 63 M (Fig. 3). This was weaker than 
that of norisoprenoids, monoterpenoid acetates and 
phenylcyclohexane but tighter than most monoterpenoids.41 
The NADH oxidation activity (240 min1) was higher than the 
initial rate observed with naphthalene and it was linear 
throughout the turnover (Table 2, Fig. S3). HPLC analysis 
revealed the formation of a single product, which coeluted with 
an authentic standard of 1-naphthylmethanol (Scheme 1, Fig. 
4). The amount of 1-naphthylmethanol was quantitated and 
both the product formation rate, 38 min1, and coupling 
efficiency, 16%, for the turnovers were determined. 
Figure 3 Dissociation constant analysis of CYP101B1 with 1-methylnaphthalene 
(2.1 µM enzyme/ Kd 63 µM, peak to trough, A390-A420). 
Table 2. Substrate binding, kinetic and coupling efficiency data for the turnovers of 
CYP101B1 with alkyl substituted naphthalene and biphenyl substrates. The turnover 
activities were measured using a ArR:Arx:CYP101B1 concentration ratio of 1:10:1 (0.5 
μM CYP enzyme, 50 mM Tris, pH 7.4). N is the NADH oxidation rate, PFR the product 
formation rate and C is the coupling efficiency, which is the percentage of NADH utilised 
for the formation of products. Rates are reported as mean  S.D. (n  3) and given in 
nmol.nmol-CYP–1.min–1. 











     
1-methylnaphthalene  55%[a] 240  17 38  10 16 
2-methylnaphthalene 40% 212  24 57  18 26 
2,7-dimethylnaphthalene 30% 448  44 79  10 18 
1-ethylnaphthalene 20% 482  7 18  3 4 
2-ethylnaphthalene 20% 284  5 20  1 7 
2-methylbiphenyl 20% 257  9 35  8 14 
3-methylbiphenyl 20% 127  10 30  12 23 
4-methylbiphenyl 20% 176  10 39  7 22 
4-biphenylmethanol 10% 106  8 11  4 12 
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Figure. 4 HPLC analysis of the in vitro CYP101B1 turnovers of (a) 1-
methylnaphthalene overlaid with 1-naphthylmethanol, (b) 2-methylnaphthalene 
overlaid with 2-naphthylmethanol, (c) 1-ethylnaphthalene overlaid with 1-
naphthyl-1-ethanol and (d) 2,7-dimethylnaphthalene overlaid with the whole-cell 
oxidation turnover of the same substrate. Turnovers are shown in black the 
internal standard (IS), impurities (*) and substrate are labelled. The HPLC runs of 
the authentic product standards (A) are shown in red for (a-c). In (d) the whole-
cell product turnover which generated 7-methyl-2-naphthoic acid (B) is in red. A 
different internal standard, 4-methoxycinnamic acid, was used in the turnover of 
1-ethylnaphthalene as 9-fluorenone coeluted with the 1-naphthyl-1-ethanol 
product. 
2-Methylnaphthalene induced a lower spin state shift, 40% 
HS, than 1-methylnaphthalene and a similar shift to 2-naphthol 
(Fig. S1). The NADH oxidation activity of CYP101B1 in the 
presence of 2-methylnaphthalene was 212 min1. A single 
product, 2-naphthylmethanol, identified by HPLC coelution, 
was formed at a product formation rate of 57 min1 (Scheme 1, 
Fig. 4). The higher activity of 2-methylnaphthalene oxidation 
compared to 1-methylnaphthalene arose as a result of greater 
coupling efficiency of the reducing equivalents to product 
formation, 26% (Table 2). 
The effect of the size of the alkyl substituent on the binding 
and biocatalytic parameters of CYP101B1 was investigated by 
testing 1- and 2-ethylnaphthalene. Addition of both substrates 
induced spin state shifts of only 20% HS, which was lower than 
the equivalent methylnaphthalenes but comparable to 
naphthalene. The NADH oxidation activity of CYP101B1 with 1-
ethylnaphthalene (482 min1) was greater than that of 2-
ethylnaphthalene (284 min1) and both methylnaphthalenes 
(Table 2). A single product was generated from each of the 
turnovers of 1- and 2-ethylnaphthalene. These coeluted with 1-
naphthyl-1-ethanol and 2-naphthyl-1-ethanol, respectively 
(Scheme 1, Fig. 4, Fig S5). The product formation rate with 1-
ethylnaphthalene (18 min1) was lower than 2-
ethylnaphthalene (20 min1). Despite the higher NADH 
oxidation rates and the greater reactivity of the benzylic 
methylene group of these substrates, versus the methyl group 
of the methylnaphthalenes, the coupling of reducing 
equivalents to product formation decreased (both <10%, Table 
2). The lower coupling efficiencies and product formation rates 
observed for both of these substrates compared to the 
methylnaphthalenes is consistent with the reduced spin state 
shifts observed on substrate binding.  
Chiral GC analysis showed that the turnover of 2-
ethylnaphthalene generated a single enantiomer which 
coeluted with (R)-(+)-1-(2-naphthyl)ethanol (Fig. S2(e)). The 
enantioselectivity of 1-ethylnaphthalene oxidation was lower 
with both enantiomers of 1-naphthyl-1-ethanol were generated 
though there was a significant excess of one stereoisomer ( 
84% ee, Fig. S2(f)). Overall the larger ethyl naphthalenes do not 
appear to be as well tolerated in the active site of CYP101B1 as 
methyl naphthalenes and they are bound in a less favoured 
position for efficient CH bond oxidation. However they must 
be positioned in such a way that there is a strong preference for 
abstraction of one of the enantiotopic hydrogens of the 
methylene group. 
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2,7-Dimethylnaphthalene induced a lesser spin state shift 
on binding to CYP101B1, 30% HS, than either 1- or 2-
methylnaphthalene. The activity of CYP101B1 with 2,7-
dimethylnaphthalene was high as measured by NADH oxidation 
(448 min1, Table 1). The product formation rate was the 
highest of all the substituted naphthalenes (79 min1) and the 
coupling efficiency (18%) was comparable to that of the 
methylnaphthalenes. The in vitro turnover produced a single 
oxidation product (Fig. 4d). The most likely product, which could 
arise from benzylic CH bond hydroxylation of 2,7-
dimethylnaphthalene, was not available for coelution so a 
whole-cell oxidation turnover was conducted to generate 
metabolites for characterisation. The in vivo turnover converted 
all the added substrate (1 mM, Fig. 4d) into a single oxidation 
product after 20 hours. The metabolite from the whole-cell 
oxidation was isolated and identified by NMR as 7-methyl-2-
naphthoic acid. The characteristic signal was the chemical shift 
of 168.38 ppm in the 13C NMR, corresponding to a carboxylic 
acid, and this combined with the lack of CH2OH peak and 
presence of all six aromatic protons in 1H NMR allowed 
identification (Fig. S6). However this naphthoic acid metabolite 
did not coelute with the product from the in vitro enzyme 
turnovers. 7-Methyl-2-naphthoic acid was reduced using an 
excess of lithium aluminium hydride and the single product 
generated was found to coelute with that obtained in the 
enzyme turnover assays. NMR analysis of this product 
confirmed it was the expected metabolite, 2-(7-
methylnaphthyl)methanol (Fig. S7). In the in vitro turnover the 
limiting amount of NADH compared to substrate, precludes the 
further oxidation of 2-(7-methylnaphthyl)methanol but in the 
whole-cell oxidation system all of the substrate was converted 
to the alcohol product, which is then further oxidised to the 
carboxylic acid (Scheme 1). Presumably this occurs via the 
aldehyde, though this intermediate product was not observed 
in either the in vivo or in vitro turnovers. The total conversion of 
1 mM substrate into the carboxylic acid in the whole-cell 
oxidations corresponds to approximately 4500 turnovers based 
on an enzyme concentration of 0.65 µM.37 
Methylbiphenyls with the substituent at the 2-, 3- and 4-
positions were also investigated (Fig. 1). All three compounds 
induced a small shift to the high spin state upon binding to 
CYP101B1 (~20%, HS Fig. S1). This was greater than biphenyl but 
lower than the equivalent phenylphenols (Table1). The NADH 
oxidation activity of CYP101B1 after addition of the 
methylbiphenyls was similar to that of biphenyl but faster than 
all the phenylphenols (Table 1) and varied as follows; 2-
methylbiphenyl > 1-methylnaphthalene > 2-methylnaphthalene 
> 4-methylbiphenyl > 3-methylbiphenyl. That of 3-
methylbiphenyl (127 min1) was approximately half that of 2-
methylbiphenyl (257 min1, Table 2). Overall the product 
formation activity of 2-methylbiphenyl and 3-methylbiphenyl 
were similar (30 to 35 min1; Table 2). The in vitro turnovers of 
2- and 3-methylbiphenyl generated 2- and 3-biphenylmethanol, 
respectively, as the sole products (Scheme 2, Fig. 5). 2-
Biphenylmethanol was identified by HPLC coelution 
experiments with an authentic product standard (Fig. 5a). 3-
Biphenylmethanol was generated using the whole-cell 
oxidation system, purified by silica chromatography and 
identified by NMR, the 2H signal at 4.77 ppm and the signals of 
nine hydrogens in the aromatic region allowed characterisation 
(Fig. S8). There was no evidence of further oxidation of either 
product when using the whole-cell oxidation system, despite 
only a small amount of 3-methylbiphenyl substrate remaining. 
Low levels of 3-phenylbenzaldehyde were detected by GC-MS 
analysis of the in vitro turnovers of 3-methybiphenyl when 
excess NADH (4 mM) was used (Fig. S4). 
Scheme 2 The products formed from the CYP101B1 catalysed oxidation of 
biphenyl substrates. 
The turnover of 4-methylbiphenyl was more complex and 
resulted in the formation of two metabolites. The product 
formation rate of the 4-methylbiphenyl (39 min1) and the 
coupling efficiency (22%) resembled those of 2- and 3-
methylbiphenyl despite the different P450 mechanisms 
involved in aromatic versus aliphatic oxidation.63 The minor 
product 4-biphenylmethanol (30%) was identified via HPLC 
coelution with an authentic product standard (Fig. 5c). As with 
2,7-dimethylnaphthalene we considered that the major product 
(70%) may arise from further oxidation of the 4-
biphenylmethanol product generating the aldehyde or the 
carboxylic acid. Whole-cell oxidation turnovers were conducted 
with 4-biphenylmethanol and 4-methylbiphenyl. The product 
from the oxidation of 4-biphenylmethanol did not coelute with 
any peaks in the 4-methylbiphenyl turnover (Fig. 5d). Therefore 
the unidentified product from the whole-cell turnover of 4-
methylbiphenyl was isolated by silica column chromatography 
and characterised. The 3H methyl singlet (2.38 ppm) and the 
distinctive signals of the two para-substituted rings (8H) in the 
aromatic region allowed identification as 4`-(4-
methylphenyl)phenol (Scheme 2, Fig. S9). The product of 
CYP101B1 catalysed oxidation of 4-biphenylmethanol was also 
isolated and characterised by NMR as 4`-(4-
hydroxyphenyl)benzyl alcohol (Fig. S10). The NADH oxidation 
rate, product formation rate and the coupling efficiency of the 
turnover of 4-biphenylmethanol were also measured and found 
to be lower than those of the methylbiphenyls (Table 2). 
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Fig. 5 HPLC analysis of the in vitro CYP101B1 turnovers of (a) 2-methylbiphenyl 
overlaid with 2-biphenylmethanol, (b) 3-methylbiphenyl, (c) 4-methylbiphenyl 
overlaid with 4-biphenylmethanol and (d) 4-methylbiphenyl overlaid with the 
turnover of 4-biphenylmethanol. Turnovers are shown in black the internal 
standard (IS), impurities (*) and substrate are labelled. The HPLC chromatograms 
of the authentic product standards (A) are shown in red for (a) and (b). In (c) and 
(d) the peak labelled A is the 4`-(4-methylphenyl)phenol major product. In (c) the 
peak labelled B is 4-biphenylmethanol and in (d) it is 4`-(4-hydroxyphenyl)benzyl 
alcohol. 
4-Methylbiphenyl is unusual in that the major product arises 
from oxidation at an aromatic CH bond with the minor product 
being hydroxylation at the more reactive benzylic methyl group. 
In addition, unlike 2,7-dimethylnaphthalene further oxidation 
to the carboxylic acid is less favoured when compared to 
aromatic oxidation on the other benzene ring. This substrate 
must be bound in at least two orientations with the most 
favourable leading to oxidation of the aromatic CH bond. In 
the second orientation the methyl group would be located close 
enough to the heme iron-oxo intermediate to favour CH bond 
abstraction at the sp3 hydrogens.  
The alcohol oxygen of 4-biphenylmethanol, may favour 
binding of the substrate in an orientation with the para 
aromatic ring closest to the heme iron. This would be in broad 
agreement with the regioselectivity observed with the oxygen 
containing norisoprenoids and monoterpenoid acetates. It is of 
note that 4-methylbiphenyl and 4-biphenylmethanol are the 
only two substrates tested so far with CYP101B1 where 
oxidation at an aromatic CH bond is preferred over aliphatic 
oxidation. The CYP101B1 catalysed oxidation of 
phenylcyclohexane, p-cymene and the other methyl substituted 
naphthalenes and biphenyls favoured aliphatic hydroxylation. 
4-Methylbiphenyl and 4-biphenylmethanol must have a shape 
which allows them to bind in a different orientation in the 
substrate binding pocket of CYP101B1.  
The majority of the substrates are presumably held in 
orientations such that that the initial formation of the arene 
oxide intermediate in the NIH shift mechanism64, 65 or Shaik’s 
porphyrin mediated proton-shuttle mechanism,63 required for 
aromatic oxidation, must be impeded (Scheme S1). If aromatic 
oxidation does occur via an arene oxide intermediate this 
pathway could also generate 3-(4-methylphenyl)phenol. This 
product was not observed, perhaps as it would be formed via a 
less favoured cationic intermediate (Scheme S1). 
With the exception of 4-methylbiphenyl the alkyl 
substituted aromatic substrates hydroxylated by CYP101B1 
with high regioselectivity for the benzylic CH bonds of the 
methyl or ethyl substituent. This is in accordance with the 
reactivity of the CH bonds in these substrates. The preference 
for aliphatic versus aromatic oxidation, may reflect the different 
mechanisms and energies of aromatic versus aliphatic CH 
bond oxidation. The size and planar nature of the naphthalene 
and biphenyl molecules may limit the motion of the substrate 
in the active site. The alkyl group of the substrates is likely to be 
held close to the heme in at least one of the preferred binding 
orientations in order to allow the generation of the observed 
products.  
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Finally we used CYP101B1 to oxidise the nonsteroidal anti-
inflammatory drug molecule diclofenac. Diclofenac consists of 
two aromatic rings linked through an amine group 
(diphenylamine like), and contains a carboxylic acid moiety as 
well as two chlorines (Fig. 1). The carboxylate group oxygen 
could potentially mimic the ketone functionality of 
norisoprenoids, which bind efficiently to CYP101B1. The binding 
of diclofenac induced a minimal shift in the spin state of 
CYP101B1, ~5% HS, upon binding. The NADH oxidation rate 
could not be accurately determined as the substrate absorbs 
strongly at 340 nm. However HPLC analysis of a whole-cell 
oxidation turnover of diclofenac indicated that a single product 
was formed (Fig. S11). This was generated in larger quantities 
using the whole-cell oxidation system and purified by silica gel 
chromatography. The product was identified as 4`-
hydroxydiclofenac by matching its NMR data to that reported in 
the literature (Scheme 3).46, 47  
Scheme 3 The product formed from the CYP101B1 turnover with diclofenac. The 
numbering system used for diclofenac is the same as that from Marco-Urrea et 
al.46 
As a control we tested diphenylmethane with the CYP101B1 
enzyme. This was a poor substrate for CYP101B1 but showed 
low activity with hydroxylation occurring at the benzylic CH 
bonds (Fig. S4 and S12). The selective oxidation of the drug 
molecule diclofenac by “wild-type” CYP101B1 is a promising 
step towards using this system for drug metabolite production 
from molecules with similar structural features to naphthalene, 
biphenyl and diclofenac. CYP101B1 could be used to mimic the 
drug oxidising properties of mammalian P450 enzymes and thus 
allow the facile generation of hydroxylated drug metabolites in 
larger quantities.  
Conclusions 
We have shown that CYP101B1 is capable of oxidising a range 
of molecules containing two aromatic rings. The oxidation of 
naphthalene and biphenyl were inefficient and one of the 
products generated during the turnover of naphthalene could 
compete with CYP101B1 for electrons from the ArR/Arx 
electron transfer system via redox cycling. This form of 
uncoupling of reducing equivalents would make regular 
cytochrome P450 enzymes unsuitable biocatalysts for 
naphthalene oxidation and using alternate systems such as 
perooxygenases may be more effective. CYP101B1 was able to 
efficiently and selectively oxidise a range of alkyl substituted 
naphthalene and biphenyl substrates. The reactions are, in 
general, regioselective for oxidation at the more reactive 
benzylic carbons. 4-Methylbiphenyl was the exception being 
preferably oxidised to 4`-(4-methylphenyl)phenol with 4-
biphenylmethanol being formed as a minor product. The 
oxidation of both ethylnaphthalenes by CYP101B1 was also 
highly enantioselective. The aromatic drug molecule diclofenac, 
which also contains two aromatic rings, was regioselectively 
hydroxylated to 4′-hydroxydiclofenac. When incorporated into 
a whole-cell oxidation system, with the physiological electron 
transfer partners, ArR and Arx, CYP101B1 was capable of 
generating the oxidised metabolites of the substituted 
naphthalenes and biphenyls in sufficient amounts for 
characterisation. In certain instances further oxidation products 
were formed using the whole-cell oxidation system for example 
2,7-dimethylnaphthalene oxidation generated the further 
oxidation product 7-methyl-2-naphthoic acid as the only 
metabolite. 
CYP101B1 was therefore able to bind and regioselectively 
oxidise alkyl substituted aromatic molecules. The product 
formation activities are comparable or in excess to other 
available systems and the selective oxidation and total 
turnovers achieved using a whole-cell oxidation system with 
CYP101B1 with these hydrophobic substrates is suited to the 
biocatalytic generation of hydroxylated products. Previously we 
have shown than CYP101B1 has a strong preference for 
substrates containing a carbonyl oxygen group such as 
norisoprenoids and monoterpenoid esters which presumably 
arises through some hydrophilic interactions with the residues 
that line the active site of the enzyme. The binding affinity of 
the more a polar aromatic substrates tested here could 
therefore be improved using protein engineering to increase 
the hydrophobicity of the active site. The size of the substrate 
binding pocket could also be modified to better accommodate 
these aromatic molecules. However there is currently no 
structural information available for the CYP101B1 enzyme. 
These approaches would lead to significant improvement in the 
coupling efficiency and product formation rate leading to more 
efficient biocatalytic oxidation of naphthalene and biphenyl 
based substrates. 
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